VSS Capital Partners Makes Growth Investment in Eximia Research Network

Eximia Research Network Acquires Tidewater Clinical Research

August 2, 2024

Healthcare Services

Eximia Research Network has acquired Tidewater Clinical Research, integrating the Virginia-based clinical trial site into its national network to expand geographic reach and therapeutic capabilities. The deal brings Tidewater's long-standing expertise in Women's Health and Ophthalmology and a ~97,000-patient database into Eximia's PE-backed platform (investor: VSS Capital Partners); Viking Mergers & Acquisitions advised the sellers.

VSS Capital Partners Completes Platform Investment in Treya Partners

October 7, 2024

Consulting

VSS Capital Partners completed a platform investment in Treya Partners, a San Francisco–based procurement and strategic sourcing consulting firm serving mid-market private equity-backed companies. Financial terms were not disclosed; Treya will partner with VSS to expand product offerings and pursue strategic M&A as part of a buy-and-build growth plan.

Eximia Research Acquires Integrated Clinical Trial Services (ICTS)

October 16, 2024

Healthcare Services

Eximia Research, a Raleigh-based integrated clinical research network, has acquired Integrated Clinical Trial Services, Inc. (ICTS), a dedicated clinical research clinic in West Des Moines, Iowa. The acquisition expands Eximia’s Midwest footprint and increases local patient access to clinical trials across multiple therapeutic areas including pediatrics, neurology and dermatology.

1315 Capital Leads Growth Investment in Experic

October 29, 2024

Pharmaceuticals

Experic, a Cranbury, New Jersey-based CDMO and clinical trial supply services firm, received a growth capital investment led by 1315 Capital with participation from existing investors East Seattle Partners, Harro Höfliger Packaging Systems, Inc., and Kineticos Ventures. The capital will be used to enhance Experic’s manufacturing capabilities and accelerate its international expansion to better serve biopharmaceutical clients.

Kain Capital Invests in Excelsior Integrated Medical

August 24, 2020

Healthcare Services

Kain Capital LLC has made a growth investment in Excelsior Integrated Medical, a New York City–based primary care physician group serving over 60,000 patients across 37 locations with roughly 75 providers. The capital will support Excelsior's continued shift to a value‑based, global capitation model and expansion of its provider base, with the goal of replicating the model beyond the local community.

NMS Capital Recapitalizes Exo Group

July 14, 2020

Infrastructure

NMS Capital has completed a recapitalization of Exo Group, LLC, partnering with Exo's founders and management who will remain significant shareholders. The investment will provide capital to support Exo's growth in data-driven asset inspection, remediation, engineering and training services for steel infrastructure across North America.